Every six seconds, someone on our planet suffers a snake bite, and each time, a race against the clock begins. What kind of ...

ZEISS has introduced the new ZEISS METROTOM 800 320 kV, a cutting-edge CT system that elevates the speed and precision of ...

On Tuesday evening, Ultimovacs revealed results from a phase II study with the company’s cancer vaccine UV1. The study included 118 patients with the rare but aggressive form of cancer mesothelioma.

The company made a significant move into the Swedish life science sector in March this year when it acquired the majority of Solna-based Xbrane Biopharma. Like Xbrane, Alvotech focuses on the ...

Carl Zeiss Meditec generated revenue of €1,050.5m in the first half of fiscal year 2024/25 (prior year: €947.2m), including the DORC consolidation, corresponding to growth of +10.9% (adjusted for ...

Hansa Biopharma omorganiserar och minskar personalstyrkan med cirka 20 procent, vilket väntas spara 40–50 miljoner kronor per ...

Industrin står inför ökade krav på både prestanda och hållbarhet. Med DHS 3000 VSD+ erbjuder Atlas Copco en lösning som ...

Tio nya läkemedel rekommenderas för godkännande i EU, däribland GSK:s cancerläkemedel som nu ges en ny chans efter ...

Under 2024 tog Läkemedelsverket emot drygt 13 000 rapporter om misstänkta biverkningar. Allra flest rapporter rörde ...

Kisunla eller Leqembi? Konkurrensen mellan Eli Lilly och Bioartics fortsätter. Där konkurrenten får godkänt går den andre bet ...